This week in Orthopaedic Oncology

Oct 5–11, 2026 · 5 new studies, 5 reviews · Orthopaedic Oncology archive · All weeks

The new Orthopaedic Oncology research The Reduction sent the week of Oct 5–11, 2026, with the week’s most recent reviews, each with a one-line summary.

Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.

New research

  1. What Is the Natural History and Likelihood of Progression of Indeterminate Pulmonary Nodules in Patients With Extremity Osteosarcoma?

    Clinical Orthopaedics and Related Research · Oct 09 2026 · PubMed

    In extremity osteosarcoma, 58% of indeterminate pulmonary nodules progressed and 25% became confirmed metastases; no nodule feature predicted progression, but these patients had worse 2-year survival (55% vs 76%), supporting vigilant surveillance.

  2. Survival and Reoperation After Intralesional Procedures Versus Resection and Reconstruction for Renal Cell Carcinoma Bone Metastases.

    Journal of Bone and Joint Surgery (American) · Oct 07 2026 · PubMed

    In 105 RCC long-bone metastasis patients, intralesional surgery had more mortality overall but not in solitary metastases, with similar reoperation rates versus resection and reconstruction, so both are reasonable options.

  3. Clinical outcomes of the LORDS strategy for thoracolumbar spinal metastases: a retrospective cohort study.

    European Spine Journal · Oct 03 2026 · PubMed

    In 238 patients operated for spinal metastases, surgery concordant with the LORDS strategy was linked to shorter hospitalization and longer overall and local progression-free survival than non-concordant surgery, though prospective validation is needed.

  4. Outcomes of Surgical Interventions in Children With Fibrous Dysplasia/McCune-Albright Syndrome.

    Journal of Pediatric Orthopaedics · Oct 02 2026 · PubMed

    In 45 children with fibrous dysplasia/McCune-Albright syndrome (64 surgical sites), mostly proximal femur surgery for impending fractures, only 42% stayed event-free at 5 years, with higher risk in girls and younger patients.

  5. Neoplasms of the Cervical Spine: Diagnostic Workup and Clinical Decision-making Algorithms.

    Clinical Spine Surgery · Sep 21 2026 · PubMed

    This narrative review summarizes the diagnostic workup and decision-making frameworks for cervical spine tumors, emphasizing multimodal imaging, biopsy, and multidisciplinary tumor boards to individualize care.

Recent reviews

  1. Intercalary Diaphyseal Endoprosthetic Reconstruction.

    JAAOS Global Research & Reviews · Jul 01 2025 · PubMed

    Review of intercalary diaphyseal endoprostheses for tumors and metastases covers designs, indications, alternatives, and results; function and complications are acceptable, but aseptic loosening remains a leading cause of failure.

  2. Tumors of the Brachial Plexus: A Critical Analysis Review.

    JBJS Reviews · Jun 01 2024 · PubMed

    Review of rare brachial plexus tumors: MRI is the main imaging tool, observe asymptomatic benign lesions, biopsy suspected malignancies despite nerve injury risk, and plan treatment at multidisciplinary tumor boards.

  3. Use of Steroids in Spine Surgery.

    Journal of the American Academy of Orthopaedic Surgeons · Jul 01 2023 · PubMed

    Reviews steroid use in spine care: helpful for preventing dysphagia after ACDF and for radicular pain injections, but not beneficial for spinal cord injury or acute low back pain, with limited evidence in spinal metastasis.

  4. Critical Review of Oncologic Medical Malpractice Claims Against Orthopaedic Surgeons.

    JAAOS Global Research & Reviews · May 01 2023 · PubMed

    Analysis of 36 oncologic malpractice cases against orthopaedic surgeons found failure to diagnose primary sarcoma was the leading allegation, most cases favored the defendant, and awards averaged about $1.67 million.

  5. Determining functional outcomes after resection and reconstruction of primary soft tissue sarcoma in the lower extremity: A review of current subjective and objective measurement systems.

    Journal of Surgical Oncology · Apr 2023 · PubMed

    Reviews the subjective and objective tools used to measure functional outcomes after lower-extremity soft tissue sarcoma resection and reconstruction, noting inconsistent methods and limitations of current measures.

← Week of Sep 28 – Oct 4, 2026

Home  ·  All weeks  ·  Archive  ·  Subscribe  ·  FAQ

© 2026 The Reduction